about
Brain glucose sensing, glucokinase and neural control of metabolism and islet functionRegulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialOvernight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesDay and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementThe use of a portable breath analysis device in monitoring type 1 diabetes patients in a hypoglycaemic clamp: validation with SIFT-MS data.Raised late pregnancy glucose concentrations in mice carrying pups with targeted disruption of H19delta13Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial.Brain glucosamine boosts protective glucoprivic feedingBAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding.Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.5-HT obesity medication efficacy via POMC activation is maintained during agingHome use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyReusable, robust, and accurate laser-generated photonic nanosensor.A parabrachial-hypothalamic cholecystokinin neurocircuit controls counterregulatory responses to hypoglycemiaComparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)Increased placental glucose transport rates in pregnant mice carrying fetuses with targeted disruption of their placental-specific Igf2 transcripts are not associated with raised circulating glucose concentrations.Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in rats.Life-threatening metabolic alkalosis in Pendred syndromeGlucokinase inhibitor glucosamine stimulates feeding and activates hypothalamic neuropeptide Y and orexin neurons.Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest riskEvaluating the Performance of a Novel Embedded Closed-loop System.Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohortUnsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus.Recurrent hypoglycemia is associated with loss of activation in rat brain cingulate cortex.Validity of triple- and dual-tracer techniques to estimate glucose appearance.Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathwaysAvoiding hypoglycaemia when treating type 1 diabetes.Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract.Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.Sex difference in physical activity, energy expenditure and obesity driven by a subpopulation of hypothalamic POMC neurons.Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated.Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.Nutritional state influences Nociceptin/Orphanin FQ peptide receptor expression in the dorsal raphe nucleus.Intracerebroventricular Catalase Reduces Hepatic Insulin Sensitivity and Increases Responses to Hypoglycemia in RatsAccuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations.Artificial pancreas: an emerging approach to treat Type 1 diabetes.Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes.
P50
Q26991502-6B4AF10A-3EEB-41AC-860C-4EE021E68CECQ28554636-8C7FD38D-FE80-4806-A9DA-F5371F70F169Q28741005-00731462-074D-4BCA-A9AD-A00F4B5F7F64Q30409243-DC64EA9B-D8C4-4A7F-A68D-5278D11C921FQ30847669-23708134-9F06-4271-AD00-C0DD319783D3Q33556605-FC0096EC-76FF-43B1-8B56-692539A9D8B9Q33750788-335AF314-2CE3-4AE3-BF84-EE5263E1950FQ33772319-01E10B20-930F-4958-BFDA-40982D3C2F5BQ34097575-1F45E54E-41A1-4EA9-B482-13236C03CE40Q34151693-F33F5E0B-EDA0-424D-8F12-51A36088EB28Q34185683-533C52DF-CE1D-4064-9D13-8D191AE9C245Q34194737-7EDF1096-A9BB-432E-9410-56854006FA82Q34420721-F93C9E4D-07B5-47AD-86A4-754C05E7CB38Q34451873-FE2674E6-4E25-4880-A3A7-6338B1225AF2Q34511505-42166C38-BF1B-482A-9527-2A07696C684DQ34572315-965AB70D-3768-465D-BA6B-3063DE89BCECQ34712765-E9E1EED8-73A2-4F9B-8973-3B20C4B658B2Q35055156-19EF0EAD-989F-4F93-8C76-D185B6FE76F9Q35097342-FC66121E-D8DD-45DF-A0EF-36C86B6E39BCQ35179907-DCB49B47-EBE5-46A3-A181-25EA1602124BQ35682761-477BEAF9-663F-41B6-A809-3FF2E0BBA545Q35684916-B4507704-3357-4FA7-A1E3-7BED1A3AECFCQ35877744-3B1FAB5B-FE31-4012-A1C9-8C4940927787Q35893486-BDA652D7-79FB-4BC3-9FBC-0284DB0D95EEQ35893491-0C0AE5AA-AF23-419C-8AE7-0B4535542ECDQ36042126-7E4ED694-3A9E-48C3-B742-408FADF28784Q36138183-CFBC31F7-593A-40F5-B70E-191033DD77F4Q36211008-AC1425C5-741C-46F2-BE2A-20179D5C6FEEQ36291620-039B7E98-E034-4641-A609-8AC5A9194A4CQ36426053-C81A96FF-2BBC-4A5B-89CD-38263F12F781Q36572849-5739F630-8BD8-4DDA-927F-D6CB44550713Q36628081-1A2BCCD9-4DE5-4F6C-ACA0-01EAF90D66D7Q36897192-E19A9C7F-DEBF-4485-BC8C-A83DCC6F8ADDQ37030123-5571644F-2585-4DA1-ADE4-14E1D93B88CBQ37331320-56990B41-B8C3-47E9-8C9C-5B8BE844B9F7Q37441099-7C72A6F1-3C7F-4D10-B6C3-DDA233B604CDQ37463874-A7B40F81-460C-4EBC-86BD-20B0051F7B79Q37489730-F06D81C0-4123-4DAD-9206-4DF3234AA453Q37538736-AB7D88CD-AB22-4606-8C06-D84238C04602Q37732203-E74BEBF9-16C8-43E3-91F0-D4FC91DD1614
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark L Evans
@nl
Mark L Evans
@sl
Mark L. Evans
@en
Mark L. Evans
@es
type
label
Mark L Evans
@nl
Mark L Evans
@sl
Mark L. Evans
@en
Mark L. Evans
@es
altLabel
Mark Evans
@en
prefLabel
Mark L Evans
@nl
Mark L Evans
@sl
Mark L. Evans
@en
Mark L. Evans
@es
P106
P1153
7404539072
P21
P31
P496
0000-0001-8122-8987